4.7 Article

Pyruvate kinase M2 regulates mitochondrial homeostasis in cisplatin-induced acute kidney injury

期刊

CELL DEATH & DISEASE
卷 14, 期 10, 页码 -

出版社

SPRINGERNATURE
DOI: 10.1038/s41419-023-06195-z

关键词

-

向作者/读者索取更多资源

Mitochondrial fragmentation is an important pathological process in acute kidney injury (AKI), leading to cell death. This study found that phosphorylation of PKM2 contributed to its dimer formation and translocation into mitochondria. Mitochondrial PKM2 binds MYH9 to promote mitochondrial fragmentation. Modulating PKM2 abundance and activity to inhibit mitochondrial translocation may alleviate renal tubular injury and cell death.
An important pathophysiological process of acute kidney injury (AKI) is mitochondrial fragmentation in renal tubular epithelial cells, which leads to cell death. Pyruvate kinase M2 (PKM2) is an active protein with various biological functions that participates in regulating glycolysis and plays a key role in regulating cell survival. However, the role and mechanism of PKM2 in regulating cell survival during AKI remain unclear. Here, we found that the phosphorylation of PKM2 contributed to the formation of the PKM2 dimer and translocation of PKM2 into the mitochondria after treatment with staurosporine or cisplatin. Mitochondrial PKM2 binds myosin heavy chain 9 (MYH9) to promote dynamin-related protein 1 (DRP1)-mediated mitochondrial fragmentation. Both in vivo and in vitro, PKM2-specific loss or regulation PKM2 activity partially limits mitochondrial fragmentation, alleviating renal tubular injury and cell death, including apoptosis, necroptosis, and ferroptosis. Moreover, staurosporine or cisplatin-induced mitochondrial fragmentation and cell death were reversed in cultured cells by inhibiting MYH9 activity. Taken together, our results indicate that the regulation of PKM2 abundance and activity to inhibit mitochondrial translocation may maintain mitochondrial integrity and provide a new therapeutic strategy for treating AKI.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据